December 2019 Tender Price
23 January 2020
CVC Credit Partners European Opportunities Limited
December 2019 Tender Price
CVC Credit Partners European Opportunities Limited (the "Company") announces the following in relation to its December 2019 Tender:
Sterling Shares1
Shares accepted for tender | 76,796,296 |
31 December 2019 NAV per Sterling Share | £1.0534 |
Tender Price | £1.0434 |
Euro Shares1
Shares accepted for tender | 2,455,926 |
31 December 2019 NAV per Euro Share | €1.0013 |
Tender Price | €0.9913 |
The Tender Price equals the NAV per Share as at 31 December 2019 minus £0.01/€0.01 (being 1% of the Placing Price), as applicable.
It is anticipated that a further announcement regarding the unconditional purchase of the Shares tendered will be made on or around 7 February 2020, and that payment for the December 2019 tender will be made on 14 February 2020.
The Basic Entitlement for the March 2020 Contractual Quarterly Tender will be 24.99% of the Euro Shares and 24.99% of the Sterling Shares held on 7 August 2019.
Terms defined in the Company's prospectus dated 29 March 2019 have the same meaning in this announcement unless otherwise defined.
CVC Credit Partners European Opportunities Limited: +44 (0)1534 625 522
Richard Boléat
BNP Paribas Securities Services S.C.A., Jersey Branch +44 (0)1534 709 181
1In respect of the Realisation Condition, the Company will submit redemption requests to the Investment Vehicle in respect of 2,439,950 Euro Company Investment Vehicle Interests (based on a net asset value of €1.007856) and 76,688,281 Sterling Company Investment Vehicle Interests (based on a net asset value of £1.054884) which has been accepted and in respect of which funds are expected to be received on or before the anticipated payment date set out above.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.